Blood glucose lowering compound
US10035839B2 · kind B2 · utility
4Cited by
2References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 16, 2017 |
| Grant date | Jul 31, 2018 |
| Priority date | — |
| Expiry date | Feb 16, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the field of medicine and the treatment of diabetes or hyperglycemia within that field. More particularly, the invention relates to a compound that lowers blood glucose, pharmaceutical compositions containing such a compound, and therapeutic uses of such a compound. The compound claimed herein comprises an A chain and a B chain, wherein the amino acid sequence of the A chain is SEQ ID NO: 1 and the amino acid sequence of the B chain is SEQ ID NO: 2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.